The nucleotide sequences were determined for the VH and VL domains of two human IgGI antibodies, Pag-1 and Fog-B, specific for the D antigen of the Rh-blood-group system. The VH-region genes of the two antibodies were derived from separate germ-line genes within the VH I gene family, but both antibodies used the same JH6 gene. The D-region genes differed from each other, and no similarity was found to known D regions. The light chain of Fog-B belongs to the VA subgroup and that of Pag-1 probably belongs to the VA _V subgroup; both light chains used the J2/3 gene. Threedimensional models of the variable domains were made, based on those of known crystallographic structure. The surface contours at the combining sites are clearly different, consistent with the evidence that the antibodies recognize different but overlapping epitopes. Some details of the molecular modelling of hypervariable regions have been deposited as Supplementary Publication SUP 50155 (6 pages) at the British Library Document Supply Centre, Boston Spa, Wetherby, West Yorkshire LS23 7BQ, U.K., from whom copies can be obtained on the terms indicated in Biochem. J. (1990) 265, 5.
INTRODUCTION
The V domains of the H and L chains of immunoglobulins are coded in the mature B-cell by single exons. These exons are derived during B-cell maturation by selection and rearrangement from many VH' VL, D, JH and JL segments (see review by Taussig, 1988) . It is of considerable interest to determine whether or not certain gene segments are selectively expressed in the V domains of human antibodies specific for a single antigen.
The recent development of methods for establishing stable cell lines derived from human B-lymphocytes by heterohybridoma formation has led to the acquisition of a number of monoclonal antibodies specific for the D antigen of the human Rh-bloodgroup system (Thompson et al., 1986; Melamed et al., 1987) . We present here the nucleotide sequences of the variable regions of two of these monoclonal antibodies, Pag-and Fog-B. The polypeptide carrying the D antigen is an erythrocyte membrane protein of molecular mass about 30 kDa (Moore et al., 1982) , and there is evidence that Pag-I and Fog-B recognize different but overlapping epitopes on the molecule (Gorick et al., 1988; Lomas et al., 1989) .
In addition to nucleotide sequencing, we have also carried out preliminary modelling of the antibody combining site by taking advantage of the similarities between the V-domain sequences of these two antibodies and the sequences of those structures whose three-dimensional conformations have already been elucidated.
METHODS
The human monoclonal antibodies Pag-1 and Fog-B were derived from different donors and have been previously described (Melamed et al., 1987) . They are IgG antibodies produced by human-mouse heterohybridomas; both are of the IgGI subclass and both have lambda light chains.
Total cytoplasmic RNA was extracted from the cell line by using the Nonidet P40 lysis method (Favaloro et al., 1980) . Poly(A)-mRNA was isolated by oligo(dT)-cellulose column chromatography. First-strand cDNA was synthesized by priming with oligonucleotides complementary to the 5' end of the CH1 [5'-GGGAAGGTGTGCACGCC-3'] and the CA [5'-AGC TCC TCA GAG GAG GG-3'] exons (kindly donated by Dr. G. Winter) and then cloned essentially as described by Gubler & Hoffman (1983) . The G-tailed cDNA was annealed with C-tailed pUC18 plasmid vector. Recombinant plasmids were used to transform Escherichia coli DH5-A by the high-efficiency method described by Hanahan (1983) . The resultant colonies were screened by using the relevant 5'-end-labelled oligonucleotide primer as a probe. Positive clones were sequenced by using the dideoxy chain-termination method (Sanger et al., 1977) (Saul et al., 1978) , Fab KOL (Marquart et al., 1980) , Fab MOPC603 (Segal et al., 1974) , Fab J539 (Suh et al., 1986) , Fab HYHEL5 (Sheriff et al., 1987) , Bence-Jones protein REI (Epp et al., 1975) and Bence-Jones protein RHE (Furey et al., 1983) were obtained from the Brookhaven Data Base (Bernstein et al., 1977) . They are referred to in the text as crystallographic antibodies. Hypervariable regions were modelled as described by Chothia et al. (1986) and Padlan & Kabat (1988) with the use of the canonical forms described by Chothia & Lesk (1987) . Conformational data for reverse turns were obtained from Chothia & Lesk (1987) , Wilmot & Thornton (1988) and Sibanda et al. (1989) were positioned by using the criteria of Ponder & Richards (1987) and McGregor et al. (1987) .
General sequence information and location of the complementary determining regions (CDRs) were obtained from Kabat et al. (1987) , and their numbering has been used whenever possible. There are a few instances where residues that would be expected to fulfil the same conformational role in different domains have different numbers in Kabat et al. (1987) . They have been given the same numbers as each other in the present text.
DNA sequences were obtained from the GenBank and EMBL Databases and amino acid sequences from the Leeds Composite Database Package. They were compared with the Pag-l and Fog-B sequences by using the GAP program of the WISCONSIN package. Secondary-structure predictions were made by using the PEPPLOT program. VH-region genes. Both heavy-chain variable regions (residues 1-94) of the two antibodies belong to the VH V family (Lee et al., 1987) ; the closest similarity in nucleotide sequence for Pag-l is with the V71 2 germ-line gene (95 % identity) and for Fog-B is with V2 1 germ-line gene (92 % identity).
JH-region genes. There is similarity between the antibodies in that they both use the J6 gene 
32 a b 33 40 Fog-B 1 ATGCCACTCCCCT CTCACCCTTCTCATTCACTCkCAGGGTCCTGGGCCCAGTCT 63 (1981) and that of the Daudi B-cell line (Buluwela et al., 1988) .
Light chains. Both light chains belong to the lambda class; the sequences for both are given in Fig. 3. VL-region genes. The closest similarity that was found to the VA nucleotide sequence of Pag-1 was that of the human VA subgroup IV chain, Ml8645 (Yamasaki et al., 1987) , with only 730% identity. On the other hand, the amino acid sequence (excluding the J region) has the closest resemblance (84 00 identity) to VA DEL (Eulitz, 1974) , which belongs to subgroup V (Leedsprot Library), but for which there is no nucleotide sequence. The close similarity to the latter indicates that the VA of Pag-1 probably belongs to subgroup V.
Fog-B belongs to the VAJ subgroup, and the nucleotide sequence has the closest similarity (95 0 identity) to that of the rearranged gene VA4G 12. There are only five differences in the base sequence, resulting in three amino acid changes (Kishimoto et al., 1989 Fog-B. This drawing is for illustrative purposes only. The models need refining as more information on CDRs becomes available and when extensive energy minimization is carried out. We expect that modelled CDRs will require relatively little adjustment except for CDR3 of both VH domains. These may require considerable revision.
Molecular modelling of hypervariable regions
The following is a brief account of the comparisons between the CDRs of Pag-1 and Fog-B and the five crystallographic antibodies upon which modelling was based. Further details are contained in the Supplementary Publication SUP 50155.
Heavy chains. CDR1. All the crystallographic VH domains have similar main-chain conformations in their first CDR region, and VH Pag-l also has the same number of CDRI residues. Modelling this region was therefore straightforward. VH Fog-B has two extra CDR1 residues and these were placed at positions 32a and 32b.
CDR2. Both Pag-1 and Fog-B have the same number of CDR2 residues as in VH NEWM, and modelling was therefore based on the latter.
CDR3. The number of residues in the third CDR regions of the crystallographic domains varies from seven to 17, and conformations are much more difficult to predict. Modelling of the CDR3 regions of Fog-B and Pag-1 was based on those of VH MOPC603 and of VH R19-9 (Lascombe et al., 1989) .
Framework regions. The framework region of VH Pag-l was based on that of VH NEWM (74 0 identity), and that of Fog-B on VH KOL (68 % identity).
Light chains. CDR1. VL Fog-B has the same number of residues as VL KOL, and eight of the 13 residues are identical. Modelling of the CDR1 region of Pag-l was also based on VL KOL, although it has two fewer residues (residues 26 and 26a in VLKOL).
CDR2. Modelling of this region was based on that of MOPC603. Both antibodies had the same number of residues, although Fog-B shows less sequence similarity than Pag-1.
CDR3. The main-chain conformations of the three available crystallographic VA chains are closely related. Modelling of this region for Fog-B was based on VL KOL, which has the same number of residues. VL Pag-I has two additional residues (93b and 93c), which were used for extending the reverse turn in this region, also based on VH KOL.
Framework regions. The greatest sequence similarity was to VL KOL in both instances (Pag-1, 70% identity; Fog-B, 7400 identity).
Stereo drawings of the three-dimensional model are shown in Fig. 4 ; the viewing position looks into the binding site along the pseudo-axis of the Fab arm. This is the same orientation as used by Kabat et al. (1987) .
DISCUSSION
One of the aims of elucidating nucleotide sequences of antibodies specific for a single antigen is to determine the extent of diversity or restriction in the use of germ-line genes. Crews et al.
(1981) studied 19 mouse immunoglobulins binding phosphocholine and concluded that virtually the entire immune response was derived from a single VH-coding sequence. It is more usual, however, to find diversity. Sanz & Capra (1987) reported that three families of antibodies were found in the response to pazidobenzenearsonate by the A/J strain of mice, but that there was some restriction in that the light chains within one of the families were probably all derived from a single germ-line gene. Mudgett-Hunter et al. (1985) found broad diversity in the response to digoxin, and Clarke et al. (1985) found that the mouse response to the Sb epitope of influenza haemagglutin also showed VH diversity, even between antibodies derived from a single mouse. Berek et al. (1985) found restriction in the primary response to oxazolone but considerable diversity in the secondary response.
The two anti-D antibodies described in the present paper show similarity in the use of J-region genes, but not in the use of VHI D or VL genes. Both antibodies use the same J6 gene in their heavy chains and the same J2/3 gene in their light chains. The VH genes both belong to the relatively uncommon VH IV family (Lee et al., 1987) (Lomas et al., 1989) . The two monoclonal antibodies described in the present paper recognize similar numbers of sites on each erythrocyte (approx. 23000), but inhibition experiments showed that, whereas Fog-B could completely inhibit the uptake of Pag-1, the latter would only partially inhibit the uptake of Fog-B (Gorick et al., 1988) . Although the exact mechanism underlying the differential inhibition results is not clear, it has been tentatively concluded that the two antibodies recognize different epitopes, which either overlap or are so close together that the occupancy of one epitope by antibody sterically hinders access to the other. This belief that the antibodies recognize different epitopes is given some support by the finding that the binding sites differ in their three-dimensional structure. Even at the level of main-chain conformation the CDR1 regions of Fog-B VL domain (loop starting at 24L; Fig. 4 ) and of Fog-B VH domain (31H) protrude further into the solvent than their counterparts in the VL domain (24L) and the VH domain (31H) of Pag-1. The main chain of the CDR3 of Pag-I VL domain (end of loop labelled 97L; Fig. 4 Contact residues between antibody and antigen have been published for three antibodies against different epitopes on the lysozyme molecule (Amit etal., 1987; Sheriff et al., 1987; Padlan et al., 1989) . Each antibody uses all six CDRs in binding antigen. The main difference in structure between Pag-1 and Fog-B and the anti-lysozyme antibodies lies in the CDR3s of the VH domains.
In the two blood-group antibodies there are 16 and 17 residues in contrast with only five to eight residues in the anti-lysozyme antibodies. However, without knowledge of the D-antigen structure it is at present impossible to speculate as to how the anti-D CDRs might be used. Anti-D antibodies bind more firmly to the antigen as the ionic strength of the medium is lowered, and there is evidence that at least three charged groups are involved (Hughes-Jones et al., 1964) . The CDRs of Fog-B and Pag-1 contain ten and eight charged groups respectively, which could be involved in the interaction.
